retatrutide mitochondria Does Preserve Muscle During Weight Loss? Retatrutide Peptide: Triple Agonist Mechanism,

A., Danska, J

Fatigue and dizziness , particularly in the early weeks of treatment

The Triple Threat: Retatrutides Glucagon Component Retatrutide is often referred to as a GIP GLP-1 Glucagon agonist , setting it apart as the first drug of its kind to target three distinct metabolic pathways

But as frontline clinicians, were left to translate complex approvals and payer requirements into something workable for patients

Switching between peptide therapies is possible under medical supervision

Not all GLP-1s are approved for obesity treatment, and this analysis includes all FDA-approved GLP-1s, including those approved for obesity (Saxenda, Weogvy, Zepbound) as well as those approved for type 2 diabetes (see Table 1)